Dirk Völkel
Impact in
- Immunology top 10%
- Macrophage Migration Inhibitory Factor
- Complement system in diseases
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
-
- Macrophage Migration Inhibitory Factor 6
- Complement system in diseases 2
-
- Prion Diseases and Protein Misfolding 4
- Co-authors
- Klaus F. Zimmermann (6 shared papers)Randolf J. Kerschbaumer (6 shared papers)Hans Peter Schwarz (4 shared papers)Gerhard Antoine (4 shared papers)Friedrich Scheiflinger (5 shared papers)Barbara Plaimauer (2 shared papers)Bernhard Lämmle (1 shared paper)Friedrich Scheiflinger (1 shared paper)
- Journals
- Transfusion (3 papers)European Journal of Cancer (1 paper)British Journal of Clinical Pharmacology (1 paper)Journal of Biological Chemistry (1 paper)European Journal of Biochemistry (1 paper)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Dirk Völkel
13 papers receiving 535 citations
Peers
Comparison fields: 5 of 71
- Immunology 365
- Hematology 115
- Nephrology 57
- Clinical Biochemistry 39
- Genetics 46
Countries citing papers authored by Dirk Völkel
This map shows the geographic impact of Dirk Völkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Völkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Völkel more than expected).
Fields of papers citing papers by Dirk Völkel
This network shows the impact of papers produced by Dirk Völkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Völkel. The network helps show where Dirk Völkel may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Völkel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 187 | |
| 2 | 2013 | 59 | |
| 3 | 2020 | 57 | |
| 4 | 2012 | 53 | |
| 5 | 2001 | 52 | |
| 6 | 2004 | 51 | |
| 7 | 2016 | 28 | |
| 8 | 2001 | 22 | |
| 9 | 1998 | 20 | |
| 10 | 2003 | 11 | |
| 11 | 2005 | 9 | |
| 12 | 2008 | 2 | |
| 13 | 2014 | 1 |
About Dirk Völkel
Dirk Völkel is a scholar working on Immunology, Molecular Biology, Cellular and Molecular Neuroscience, Hematology and Nephrology, having authored 13 papers that have together received 552 indexed citations. Recurring topics across this work include Macrophage Migration Inhibitory Factor (6 papers), Prion Diseases and Protein Misfolding (4 papers), Nuclear Receptors and Signaling (2 papers), Complement system in diseases (2 papers), Platelet Disorders and Treatments (2 papers), Cancer Mechanisms and Therapy (1 paper), Advanced Glycation End Products research (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Immunology (365 citations), Hematology (115 citations), Nephrology (57 citations), Clinical Biochemistry (39 citations) and Genetics (46 citations). Dirk Völkel has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Klaus F. Zimmermann, Randolf J. Kerschbaumer, Hans Peter Schwarz, Gerhard Antoine, Friedrich Scheiflinger, Barbara Plaimauer, Bernhard Lämmle, Friedrich Scheiflinger, Miha Furlan and Michael Thiele. Their work appears in journals such as Transfusion, European Journal of Cancer, British Journal of Clinical Pharmacology, Journal of Biological Chemistry and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.